OGEN   $0.59  0.91% Market Closed

Oragenics Inc.
Total Cash 1.35M
totalCashPerShare 0.242
EBITDA -19.64M
Total Debt 0.00
quickRatio 0.975
currentRatio 1.17
Total Revenue 7.47K
debtToEquity
Revenue/Share 0.002
ROA -2.19891
ROE -4.5471897
grossProfits
freeCashflow -9.52M
operatingCashflow -7.21M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -2632.8518
profitMargins 0.0
enterpriseValue 2.02M
forwardPE
floatShares 4.92M
sharesOutstanding 11.26M
sharesShort 197.98K
sharesShortPriorMonth 174.44K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.25%
heldPercentInstitutions 0.11%
Short Ratio help_outline 0.55%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue -0.048
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -19.52M
trailingEps -7.33%
forwardEps -10.80%
enterpriseToEbitda -0.10
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2023
institutionsCount 20
lastUpdated Nov. 6, 2024, 6:24 p.m.